The application of S4 to MAPK1 inhibition, validated by MD simulations, further showcases its potential to design potent bioactive molecules. In the future, we will apply S4 prospectively in combination with wet-lab experiments to enhance its impact in the field. Strategies to increase the structural diversity of the considered designs, such as SMILES augmentation and improved ranking protocols, could further boost its potential in medicinal chemistry.